{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T10:08:58Z","timestamp":1791281338561,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2007,11,1]],"date-time":"2007-11-01T00:00:00Z","timestamp":1193875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,11,1]],"date-time":"2007-11-01T00:00:00Z","timestamp":1193875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2007,11]]},"DOI":"10.1124\/mol.107.035337","type":"journal-article","created":{"date-parts":[[2007,8,23]],"date-time":"2007-08-23T21:19:32Z","timestamp":1187903972000},"page":"1359-1368","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":74,"title":["Ligand-Directed Signaling at the \u03b23-Adrenoceptor Produced by 3-(2-Ethylphenoxy)-1-[(1,S)-1,2,3,4-tetrahydronapth-1-ylamino]-2S-2-propanol oxalate (SR59230A) Relative to Receptor Agonists"],"prefix":"10.1016","volume":"72","author":[{"given":"Masaaki","family":"Sato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Horinouchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana S.","family":"Hutchinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bronwyn A.","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger J.","family":"Summers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/mol.107.035337_REF1","doi-asserted-by":"crossref","first-page":"11406","DOI":"10.1073\/pnas.1936664100","article-title":"\u03b2-Arrestin-mediated activation of MAPK by inverse agonists reveals distinct active conformations for G protein-coupled receptors","volume":"100","author":"Azzi","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.107.035337_REF2","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1124\/mol.64.6.1357","article-title":"Agonist and inverse agonist actions of \u03b2-blockers at the human \u03b22-adrenoceptor provide evidence for agonist-directed signaling","volume":"64","author":"Baker","year":"2003","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.107.035337_REF3","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/sj.bjp.0705017","article-title":"Evidence against \u03b23-adrenoceptors or low affinity state of \u03b21-adrenoceptors mediating relaxation in rat isolated aorta","volume":"138","author":"Brahmadevara","year":"2003","journal-title":"Br J Pharmacol"},{"key":"10.1124\/mol.107.035337_REF4","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0022-3565(24)34946-8","article-title":"Potent and selective human \u03b23-adrenergic receptor antagonists","volume":"290","author":"Candelore","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/mol.107.035337_REF5","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1128\/MCB.24.7.3057-3067.2004","article-title":"p38 mitogen-activated protein kinase is the central regulator of cyclic AMP-dependent transcription of the brown fat uncoupling protein 1 gene","volume":"24","author":"Cao","year":"2004","journal-title":"Mol Cell Biol"},{"key":"10.1124\/mol.107.035337_REF6","doi-asserted-by":"crossref","first-page":"38131","DOI":"10.1074\/jbc.C000592200","article-title":"Direct binding of activated c-Src to the \u03b23-adrenergic receptor is required for MAP kinase activation","volume":"275","author":"Cao","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.107.035337_REF7","doi-asserted-by":"crossref","first-page":"27077","DOI":"10.1074\/jbc.M101049200","article-title":"\u03b2-Adrenergic activation of p38 MAP kinase in adipocytes: cAMP induction of the uncoupling protein 1 (UCP1) gene requires p38 MAP kinase","volume":"276","author":"Cao","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.107.035337_REF8","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1124\/mol.105.013060","article-title":"What\u2019s for lunch at the conformational cafeteria?","volume":"67","author":"Clarke","year":"2005","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.107.035337_REF9","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0014-2999(98)00146-0","article-title":"Influence of \u03b2-adrenoceptor agonists on the pulmonary circulation. Effects of a \u03b23-adrenoceptor antagonist, SR59230A","volume":"348","author":"Dumas","year":"1998","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/mol.107.035337_REF10","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/S0167-4889(01)00070-2","article-title":"Analysis of inhibition by H89 of UCP1 gene expression and thermogenesis indicates protein kinase A mediation of \u03b23-adrenergic signalling rather than \u03b23-adrenoceptor antagonism by H89","volume":"1538","author":"Fredriksson","year":"2001","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/mol.107.035337_REF11","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1124\/mol.106.026716","article-title":"Distinct signaling profiles of \u03b21and \u03b22-adrenergic receptor ligands toward adenylyl cyclase and mitogen-activated protein kinase reveals the pluridimensionality of efficacy","volume":"70","author":"Galandrin","year":"2006","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.107.035337_REF12","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0026-895X(24)12022-6","article-title":"Stimulation of the extracellular signal-regulated kinase 1\/2 pathway by human \u03b23 adrenergic receptor: new pharmacological profile and mechanism of activation","volume":"55","author":"Gerhardt","year":"1999","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.107.035337_REF13","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0014-2999(01)00854-8","article-title":"Agonistic activity of SR59230A at atypical \u03b2-adrenoceptors in guinea pig gastric fundus and duodenum","volume":"416","author":"Horinouchi","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/mol.107.035337_REF14","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1038\/sj.bjp.0704654","article-title":"Mouse \u03b23aand \u03b23b-adrenoceptors expressed in Chinese hamster ovary cells display identical pharmacology but utilize distinct signaling pathways","volume":"135","author":"Hutchinson","year":"2002","journal-title":"Br J Pharmacol"},{"key":"10.1124\/mol.107.035337_REF15","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1124\/jpet.104.076901","article-title":"Evidence for pleiotropic signaling at the mouse \u03b23-adrenoceptor revealed by SR59230A [3-(2-ethylphenoxy)-1-[(1,S)-1,2,3,4-tetrahydronapth-1-ylamino]-2S-2-propanol oxalate]","volume":"312","author":"Hutchinson","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/mol.107.035337_REF16","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/S1359-6446(03)02783-1","article-title":"The secret lives of GPCRs","volume":"8","author":"Kenakin","year":"2003","journal-title":"Drug Discov Today"},{"key":"10.1124\/mol.107.035337_REF17","doi-asserted-by":"crossref","first-page":"7545","DOI":"10.1128\/MCB.21.22.7545-7557.2001","article-title":"Trophic factor withdrawal: p38 mitogen-activated protein kinase activates NHE1, which induces intracellular alkalinization","volume":"21","author":"Khaled","year":"2001","journal-title":"Mol Cell Biol"},{"key":"10.1124\/mol.107.035337_REF18","doi-asserted-by":"crossref","first-page":"22670","DOI":"10.1074\/jbc.M909093199","article-title":"\u03b23and \u03b11-adrenergic Erk1\/2 activation is Srcbut not Gi-mediated in Brown adipocytes","volume":"275","author":"Lindquist","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.107.035337_REF19","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1476-5381.1996.tb15209.x","article-title":"Functional identification of rat atypical \u03b2-adrenoceptors by the first \u03b23-selective antagonists, aryloxypropanolamino tetralins","volume":"117","author":"Manara","year":"1996","journal-title":"Br J Pharmacol"},{"key":"10.1124\/mol.107.035337_REF20","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1038\/sj.bjp.0704537","article-title":"Stimulation of \u03b23-adrenoceptors causes phosphorylation of p38 mitogen-activated protein kinase via a stimulatory G protein-dependent pathway in 3T3\u2013L1 adipocytes","volume":"135","author":"Mizuno","year":"2002","journal-title":"Br J Pharmacol"},{"key":"10.1124\/mol.107.035337_REF21","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0022-3565(24)37973-X","article-title":"Pharmacological inhibition of protein kinases in intact cells: antagonism of \u03b2-adrenergic receptor ligand binding by H-89 reveals limitations of usefulness","volume":"288","author":"Penn","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/mol.107.035337_REF22","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1124\/jpet.105.091736","article-title":"Functional domains of the mouse \u03b23-adrenoceptor associated with differential G protein coupling","volume":"315","author":"Sato","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/mol.107.035337_REF23","doi-asserted-by":"crossref","first-page":"12017","DOI":"10.1074\/jbc.274.17.12017","article-title":"The \u03b23-adrenergic receptor activates mitogen-activated protein kinase in adipocytes through a Gi-dependent mechanism","volume":"274","author":"Soeder","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.107.035337_REF24","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0165-6147(97)89799-4","article-title":"The \u03b23-adrenoceptor constitutes indeed a versatile receptor","volume":"18","author":"Strosberg","year":"1997","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/mol.107.035337_REF25","doi-asserted-by":"crossref","first-page":"22165","DOI":"10.1074\/jbc.M502352200","article-title":"Probing the \u03b22-adrenoceptor binding site with catechol reveals differences in binding and activation by agonists and partial agonists","volume":"280","author":"Swaminath","year":"2005","journal-title":"J Biol Chem"},{"issue":"5","key":"10.1124\/mol.107.035337_REF26","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1161\/01.RES.0000238387.85144.92","article-title":"Identification of cell cycle regulatory and inflammatory genes as predominant targets of p38 mitogen-activated protein kinase in the heart","volume":"99","author":"Tenhunen","year":"2006","journal-title":"Circ Res"},{"key":"10.1124\/mol.107.035337_REF27","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1096\/fj.05-5618fje","article-title":"p38 Kinase rescues failing myocardium after myocardial infarction: evidence for angiogenic and anti-apoptotic mechanisms","volume":"20","author":"Tenhunen","year":"2006","journal-title":"FASEB J"},{"key":"10.1124\/mol.107.035337_REF28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/jpet.106.104463","article-title":"Functional selectivity and classical concepts of quantitative pharmacology","volume":"320","author":"Urban","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/mol.107.035337_REF29","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/S0022-3565(24)35155-9","article-title":"RWJ 67657, a potent, orally active inhibitor of p38 mitogen-activated protein kinase","volume":"291","author":"Wadsworth","year":"1999","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24046455?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24046455?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/mol.107.035337","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T04:53:02Z","timestamp":1739940782000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X24046455"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,11]]}},"alternative-id":["S0026895X24046455"],"URL":"https:\/\/doi.org\/10.1124\/mol.107.035337","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.12818980.14100084","asserted-by":"object"}]},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ligand-Directed Signaling at the \u03b23-Adrenoceptor Produced by 3-(2-Ethylphenoxy)-1-[(1,S)-1,2,3,4-tetrahydronapth-1-ylamino]-2S-2-propanol oxalate (SR59230A) Relative to Receptor Agonists","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/mol.107.035337","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2007 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}